mmccosk has a point about the sensitivity/specificity. It is good but not great, especially for a cancer diagnosis. However the sensitivity is a big improvement over currently available tests. I'd rather get this test done than the current test if I was getting screened and at risk. used as a screening test this can still add value to clinical practice and make the company good money. i think it is a good result.
I think also a very nice sign about their platform for developing diagnostic tests
Ann: OVARIAN CANCER CLINICAL STUDY RESULTS, page-84
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
59.0¢ |
Change
-0.010(1.67%) |
Mkt cap ! $65.06M | |||
| Open | High | Low | Value | Volume |
| 60.0¢ | 60.0¢ | 59.0¢ | $17.47K | 29.17K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 41547 | 58.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 61.0¢ | 13799 | 4 |
View Market Depth
| Last trade - 15.51pm 26/07/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |